by The global bioanalytical testing services market size was estimated to be around US$ 10.39 billion in 2022. It is projected to reach US$ 10.39 billion by 2032, indicating a compound annual growth rate (CAGR) of 9.02% from 2023 to 2032.
Key Takeaways:
- North America generated more than 47% of revenue share in 2022.
- By Test Type, the bioavailability segment contributed to the largest revenue share in 2022.
- By Application, the oncology segment is expected to expand at the fastest CAGR between 2023 and 2032.
The market research report on the Bioanalytical testing services market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of Bioanalytical testing services products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.
Get a Sample: https://www.precedenceresearch.com/sample/3107
Bioanalytical Testing Services Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 4.78 Billion |
| Market Size by 2032 | USD 10.39 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 9.02% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Test Type, By Molecules, By Application, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Therapeutic Respiratory Devices Market Size to Garner USD 40.01 Billion by 2032
The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.
Focusing on the global Bioanalytical testing services market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the Bioanalytical testing services market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.
Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of Bioanalytical testing services products across different countries and applications.
Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.
The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.
This in-depth research report offers valuable insights into the Bioanalytical testing services market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.
The competitive landscape section of the report provides detailed information on Bioanalytical testing services market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the Bioanalytical testing services market.
Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Key Players
- PPD, Inc.
- ICON Plc
- Charles River Laboratories International
- Covance, Inc.
- IQVIA
- Syneos Health
- SGS SA
- Toxikon
- Intertek Group Plc
- Pace Analytical Services LLC
Bioanalytical Testing Services Market Segmentations
By Test Type
- Pharmacokinetic
- Pharmacodynamics
- Bioavailability
- Bioequivalence
By Molecules
- Small Molecules
- Large Molecules
By Application
- Cardiology
- Gastroenterology
- Neurology
- Oncology
- Others
By End User
- Pharmaceutical and Biopharmaceutical Companies
- Contract Development and Manufacturing Organizations
- Contract Research Organizations
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Bioanalytical Testing Services Market
5.1. COVID-19 Landscape: Bioanalytical Testing Services Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Bioanalytical Testing Services Market, By Test Type
8.1. Bioanalytical Testing Services Market, by Test Type, 2023-2032
8.1.1. Pharmacokinetic
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Pharmacodynamics
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Bioavailability
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Bioequivalence
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Bioanalytical Testing Services Market, By Molecules
9.1. Bioanalytical Testing Services Market, by Molecules, 2023-2032
9.1.1. Small Molecules
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Large Molecules
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Bioanalytical Testing Services Market, By Application
10.1. Bioanalytical Testing Services Market, by Application, 2023-2032
10.1.1. Cardiology
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Gastroenterology
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Neurology
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Oncology
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Bioanalytical Testing Services Market, By End User
11.1. Bioanalytical Testing Services Market, by End User, 2023-2032
11.1.1. Pharmaceutical and Biopharmaceutical Companies
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Contract Development and Manufacturing Organizations
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Contract Research Organizations
11.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Bioanalytical Testing Services Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.1.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.1.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Forecast, by End User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End User (2020-2032)
Chapter 13. Company Profiles
13.1. PPD, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. ICON Plc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Charles River Laboratories International
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Covance, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. IQVIA
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Syneos Health
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. SGS SA
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Toxikon
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Intertek Group Plc
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Pace Analytical Services LLC
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
